Literature DB >> 25284377

Comment on: levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

JayaPrakash Sahoo1, Sadishkumar Kamalanathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25284377     DOI： 10.1007/s00296-014-3145-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  6 in total

Review 1.  The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

Authors:  Daniel J Drucker; Michael A Nauck
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

2.  Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

Authors:  Suncica Buljevic; Dijana Detel; Lara Baticic Pucar; Radovan Mihelic; Tomislav Madarevic; Branko Sestan; Jadranka Varljen
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

3.  Sitagliptin (DPP-4 inhibitor)-induced rheumatoid arthritis in type 2 diabetes mellitus: a case report.

Authors:  Kazuki Yokota; Naoya Igaki
Journal:  Intern Med       Date:  2012-08-01       Impact factor: 1.271

4.  Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.

Authors:  Seoyoung C Kim; Sebastian Schneeweiss; Robert J Glynn; Michael Doherty; Allison B Goldfine; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2014-06-11       Impact factor: 19.103

5.  DPP4 inhibitor-induced polyarthritis: a report of three cases.

Authors:  Etienne Crickx; Ibrahim Marroun; Christine Veyrie; Christine Le Beller; Yoland Schoindre; Florence Bouilloud; Olivier Blétry; Jean-Emmanuel Kahn
Journal:  Rheumatol Int       Date:  2013-03-05       Impact factor: 2.631

Review 6.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.